Sudden Weakness: Why It Should Not Be Ignored

Sudden weakness — the abrupt or rapid onset of loss of strength in a limb or limbs — is one of the most important symptoms in all of medicine. Unlike gradual weakness, which develops over weeks to months and allows time for investigation and staged management, sudden weakness compresses the differential diagnosis into a smaller set of conditions, several of which are medical emergencies where outcome depends entirely on the speed of diagnosis and treatment. A stroke producing unilateral arm and leg weakness requires thrombolysis within hours; a spinal cord compression from an epidural haematoma requires surgical decompression within the same timeframe. Sudden weakness is not a symptom to observe or attribute to fatigue without assessment.

This article covers the major causes of sudden weakness, the clinical features that help distinguish them, and the level of urgency appropriate for each presentation. It addresses both sudden neurological weakness — from stroke, spinal cord compression, Guillain-Barré syndrome — and sudden functional weakness from conditions including myasthenic crisis and acute hypokalaemia. The goal is to provide the framework to recognise when sudden weakness is an emergency and to communicate the relevant features clearly when seeking medical care.

Stroke and TIA: The First Diagnosis to Consider

Stroke — sudden interruption of blood supply to a part of the brain — is the most common cause of acute onset neurological weakness and the most time-critical. The FAST acronym captures the core features for the public to recognise: Face drooping on one side; Arm weakness (one arm drifts down when both are raised); Speech difficulty (slurring, unable to find words, cannot understand speech); Time — call 999 immediately. The wider BEFAST acronym adds: Balance problems (sudden loss of balance or coordination) and Eyes (sudden visual change or loss in one or both eyes). Ischaemic stroke — the most common type, caused by arterial occlusion — can be treated with IV thrombolysis (tPA) or endovascular thrombectomy to restore blood flow. The benefit of thrombolysis declines rapidly over time: “time is brain” — approximately 1.9 million neurons are lost every minute of untreated ischaemic stroke. Treatment within 4.5 hours of symptom onset substantially improves neurological outcomes. This is why sudden neurological weakness of any kind — arm, leg, face, speech, vision — warrants a 999 call and not a GP appointment the following morning.

A transient ischaemic attack (TIA) — identical symptoms to stroke but resolving within 24 hours (usually within 60 minutes) — is not a reassuring event. It is a warning that a full stroke is imminent: the risk of stroke within 48 hours of a TIA is approximately 5–10%. Same-day urgent assessment (the TIA pathway — aspirin 300mg immediately, urgent brain and carotid imaging, antiplatelet medication) dramatically reduces the risk of subsequent stroke. Any episode of transient one-sided weakness, speech disturbance, or visual loss — even if it fully recovered — requires same-day assessment. Sudden numbness accompanying weakness on the same side of the body is a classic stroke presentation.

Spinal Cord Compression: The Back-and-Legs Emergency

Sudden or rapidly developing weakness of both legs — paraparesis — with or without sensory disturbance below a thoracic or lumbar level is acute spinal cord compression until proven otherwise. The spinal cord can be compressed by a number of mechanisms: epidural haematoma (bleeding into the epidural space, particularly in anticoagulated patients after spinal procedures or minor trauma); epidural abscess (rapidly spreading infection in immunocompromised patients or IV drug users); acute disc prolapse at the thoracic or cervical level; vertebral metastasis with cord compression; or trauma with fracture-dislocation. The key distinguishing features of spinal cord compression from stroke are: weakness affects both lower limbs symmetrically (rather than one side of the body as in stroke); there is a sensory level below which sensation is reduced or absent; bladder and bowel dysfunction (retention, incontinence) may develop; and back pain at the level of the compression may be present. Emergency MRI is the definitive investigation. Treatment — surgical decompression, high-dose dexamethasone, or radiotherapy depending on the cause — must be delivered within hours to prevent permanent paraplegia. Back pain with leg weakness is the combination that must never be attributed to a simple disc problem without neurological assessment.

Guillain-Barré Syndrome

Guillain-Barré syndrome (GBS) is an acute inflammatory demyelinating polyneuropathy — an autoimmune attack on peripheral nerve myelin — that produces progressive ascending weakness, typically beginning in the feet and legs and moving upward over days to weeks. It often follows a gastrointestinal infection (Campylobacter jejuni, most common) or a respiratory infection by 1–4 weeks. The distinctive features are: bilateral (symmetrical) limb weakness; areflexia (absent deep tendon reflexes, detectable on clinical examination); ascending progression; and autonomic instability (heart rate variability, blood pressure fluctuations). The life-threatening complication is respiratory failure from ascending paralysis reaching the diaphragm and intercostal muscles — approximately 25% of GBS patients require ventilatory support. Swallowing difficulties may precede respiratory compromise. Any patient with progressive bilateral leg weakness following an infection must be assessed urgently. FVC (forced vital capacity) monitoring is used in hospital to track respiratory reserve; a falling FVC with a threshold of 20ml/kg is the criterion for elective intubation before respiratory crisis. Treatment — IV immunoglobulin or plasmapheresis — modifies the immune attack and reduces the duration and severity of weakness.

Myasthenic Crisis

Myasthenia gravis (MG) is an autoimmune disease of the neuromuscular junction — the connection between motor nerve terminals and muscle fibres. Anti-acetylcholine receptor antibodies block the post-synaptic receptors, producing fatigable weakness: weakness that is absent at rest but appears and worsens with sustained activity and improves with rest. Classic features include ptosis (drooping eyelids, worse as the day progresses), diplopia, facial weakness, dysarthria (slurred speech), and proximal limb weakness. A myasthenic crisis — abrupt worsening of myasthenia, typically triggered by infection, surgery, or medication change — produces severe respiratory and swallowing failure that requires ICU care and ventilatory support. Worsening ptosis, increasing swallowing difficulty, and progressive breathlessness in a patient with known MG is an escalating emergency. Cholinergic crisis — excessive anticholinesterase medication — can produce a clinically similar picture and must be distinguished by the clinical context and edrophonium testing.

Hypokalaemia: A Correctable Metabolic Cause of Sudden Weakness

Severe hypokalaemia (low serum potassium — typically below 2.5 mmol/L) causes muscle weakness that can be sudden, profound, and generalised. The mechanism is hyperpolarisation of the muscle cell membrane, reducing excitability. The legs are typically affected first, with ascending weakness in severe cases. Hypokalaemic periodic paralysis — a rare familial condition affecting sodium channel genetics — produces episodic attacks of profound weakness, often triggered by carbohydrate ingestion, alcohol, or exercise, typically in young men. Secondary hypokalaemia from diarrhoea, vomiting, diuretics, or renal tubular acidosis is more common. A blood test confirming severe hypokalaemia is followed by cautious potassium replacement (IV if severe, oral if milder) with cardiac monitoring — hypokalaemia produces potentially fatal arrhythmias as well as weakness. Any sudden generalised weakness in a patient on diuretics or with significant gastrointestinal fluid losses warrants a metabolic blood panel including electrolytes.

Todd’s Paresis: Weakness After a Seizure

Todd’s paresis (Todd’s paralysis) is a transient focal neurological weakness lasting minutes to hours following a generalised or focal seizure. The mechanism involves post-ictal neuronal exhaustion in the motor cortex ipsilateral to the weakness. It can produce unilateral arm and leg weakness that closely mimics a stroke — and the distinction is critical because thrombolysis should not be given for a post-ictal state. The key differentiating feature is a witnessed seizure preceding the weakness, confusion and a post-ictal state on arrival, and recovery of strength within hours. In an unwitnessed collapse with subsequent focal weakness, the clinical picture can be indistinguishable from stroke on initial assessment, and CT brain is performed in both scenarios. Todd’s paresis itself does not require specific treatment beyond identifying and managing the underlying seizure disorder.

Functional Neurological Disorder

Functional neurological disorder (FND) — previously called conversion disorder or psychogenic weakness — is weakness or other neurological symptoms with positive findings on clinical examination that indicate the symptoms arise from a disorder of neurological function rather than structural damage. It is not rare: it accounts for a significant proportion of new neurology outpatient referrals and is the second most common reason for neurology consultation after headache. The Hoover sign (weakness of hip extension that normalises when the patient is distracted by attempted hip flexion on the opposite side) and collapsing weakness (normal power that gives way immediately with minimal pressure) are clinical signs supporting the diagnosis. FND is a genuine neurological disorder — not malingering or a psychiatric diagnosis — and responds to physiotherapy-based rehabilitation and psychological treatment. The important clinical task is to establish the diagnosis positively by finding characteristic signs, while performing appropriate investigations to exclude structural disease in any presentation where the diagnosis is uncertain.

Multiple Sclerosis and Acute Demyelinating Events

Multiple sclerosis (MS) is a chronic autoimmune demyelinating disease of the central nervous system that can present with sudden or subacute onset focal neurological deficits — including limb weakness, sensory disturbance, visual loss (optic neuritis), double vision, or cerebellar ataxia. An MS relapse (exacerbation or attack) typically develops over hours to days, peaks over 1–2 weeks, and partially or fully recovers over weeks to months. The presenting relapse of MS — the first clinical episode — is called a clinically isolated syndrome (CIS). Common first presentations include a single episode of unilateral visual loss (optic neuritis), unilateral limb weakness (motor relapse), or sensory disturbance in a limb or the trunk with a sensory level. Brain and spinal cord MRI demonstrating characteristic white matter lesions disseminated in space and time, combined with oligoclonal bands in the CSF, confirm the diagnosis. High-dose intravenous methylprednisolone is used to shorten individual relapses; disease-modifying therapies (interferons, natalizumab, ocrelizumab, and others) reduce the relapse rate and long-term disability accumulation. An acute demyelinating myelitis — inflammation of the spinal cord — produces subacute paraparesis (usually over days), a sensory level, and bladder dysfunction, and must be distinguished from compressive myelopathy by emergency MRI. Neuromyelitis optica spectrum disorder (NMOSD) — associated with anti-AQP4 and anti-MOG antibodies — produces particularly severe optic nerve and spinal cord attacks and requires different immunotherapy from standard MS.

Motor Neurone Disease: Progressive Weakness Without Sensation Loss

Motor neurone disease (MND) — known as ALS (amyotrophic lateral sclerosis) in the United States — is a progressive neurodegenerative disease affecting both upper and lower motor neurones. Unlike the acute causes of weakness covered earlier in this article, MND does not typically produce sudden weakness — the onset is gradual over months — but rapid progression can make it appear sudden to the patient. The hallmarks are progressive weakness and wasting (lower motor neurone — fasciculations, cramp, wasting) combined with upper motor neurone signs (spasticity, hyperreflexia, upgoing plantar responses), without sensory involvement (sensation is completely spared, which distinguishes it from polyneuropathy). Common presentations include progressive hand wasting and weakness (starting unilaterally), foot drop, slurred speech and difficulty swallowing (bulbar onset — a poor prognostic sign), or progressive breathlessness. The split hand sign — selective wasting of the thenar eminence and first dorsal interosseous with relative sparing of the hypothenar (FDIM sign) — is a useful early diagnostic clue. MND has no effective cure; riluzole modestly extends survival. Multidisciplinary supportive care — physiotherapy, speech and language therapy, dietetics, respiratory support — is the mainstay of management. Early palliative care discussion and advance care planning are important components. Any adult with progressive, asymmetric limb weakness and wasting with fasciculations and preserved sensation should be referred urgently to a neurologist. Progressive grip loss combined with visible muscle wasting in the hand is a presentation that always warrants neurological assessment.

Investigation of Sudden or Progressive Weakness

The investigation pathway depends on the clinical pattern and acuity. For acute onset neurological weakness of sudden onset (seconds to minutes), the first investigation is CT head to exclude haemorrhagic stroke and allow consideration of thrombolysis. For subacute onset weakness (hours to days) with a possible spinal cord level, emergency MRI spine is the priority. Blood tests covering the metabolic causes (FBC, electrolytes including potassium, magnesium, calcium, glucose, renal and liver function, thyroid function, CK) are performed in parallel. Where inflammatory or demyelinating disease is suspected, gadolinium-enhanced MRI brain and spinal cord, lumbar puncture for CSF analysis (oligoclonal bands, WBC, protein, glucose), and targeted autoantibody panels (anti-AQP4, anti-MOG, anti-NMDA, anti-VGCC for paraneoplastic causes) guide diagnosis. Nerve conduction studies and EMG distinguish peripheral nerve, neuromuscular junction, and muscle causes; the EMG is particularly valuable in MND (demonstrating widespread denervation in multiple limbs) and GBS (demonstrating demyelinating conduction block and slowed velocities). Genetic testing is increasingly available for hereditary myopathies, periodic paralysis, and hereditary motor neuropathies. The investigation of new weakness in any adult always requires imaging of the brain or spinal cord; a normal clinical examination does not exclude a significant structural lesion in a patient with recent onset symptoms.

Key Resources

• Stroke Association: Recognising Stroke Symptoms
• NHS: Guillain-Barré Syndrome
• NHS: Stroke — Symptoms and Emergency Treatment

Sudden Weakness in Specific Clinical Contexts

The context in which sudden weakness appears significantly informs the differential diagnosis and the urgency of response:

• During acute illness or fever: Sepsis produces profound generalised weakness through inflammatory cytokines, metabolic disturbance, and reduced perfusion. Viral illness can trigger Guillain-Barré syndrome 1–4 weeks after the index infection. Severe electrolyte disturbance during acute illness — hypokalaemia, hyponatraemia, hypoglycaemia — all produce weakness. Weakness during or following a significant acute illness should prompt measurement of electrolytes and glucose before neurological investigations.
• After surgery or a spinal procedure: Epidural haematoma following neuraxial anaesthesia (spinal or epidural block) or anticoagulated patients who fall is a spinal surgical emergency. New lower limb weakness or back pain developing after neuraxial anaesthesia requires immediate neurological assessment and emergency MRI to exclude cord compression. Any delay dramatically worsens outcome.
• In a patient on anticoagulants: Both intracranial haemorrhage (sudden focal neurological weakness or loss of consciousness) and epidural or subdural haematoma (progressive limb weakness and back pain) are far more likely in patients on warfarin, DOACs, or heparin — even with minor trauma or spontaneously. Anticoagulant-related bleeds are a common and preventable cause of sudden neurological disability. Reversal agents (vitamin K, prothrombin complex concentrate for warfarin; specific antidotes for DOACs) are time-critical and available in all emergency departments.

Frequently Asked Questions

What causes sudden weakness in the arms and legs?

Sudden weakness in the arms and legs — particularly affecting one side of the body — is a stroke presentation until proven otherwise and requires a 999 call. Other causes of sudden limb weakness include spinal cord compression (both legs; usually with back pain and sensory changes), Guillain-Barré syndrome (ascending bilateral weakness following infection), myasthenic crisis (in patients with known myasthenia gravis), hypokalaemia (low potassium producing generalised weakness), and Todd’s paresis (following a seizure). The sudden onset — developing over seconds to minutes — is the critical feature that distinguishes these conditions from the gradual weakness of progressive muscle or nerve disease. Any sudden onset weakness requires same-day emergency assessment.

Is sudden weakness always a stroke?

No — but sudden unilateral weakness (one side of the body) is a stroke until a clinical assessment proves otherwise, and the consequences of delaying treatment for a stroke are severe enough that emergency assessment is always warranted. Bilateral sudden weakness is more likely to reflect a spinal cord lesion, a metabolic cause (hypokalaemia, hypoglycaemia), or a neuromuscular condition. Sudden weakness that resolves completely within minutes to hours may represent a TIA (mini-stroke) — which also requires same-day emergency assessment because of the high early stroke risk. Sudden weakness without other neurological signs (normal speech, no facial asymmetry, no sensory changes) in a young person with recent viral illness raises the possibility of Guillain-Barré syndrome, which requires different management but equal urgency.

What is Guillain-Barré syndrome?

Guillain-Barré syndrome is an acute autoimmune condition in which the immune system attacks the myelin sheath of peripheral nerves, causing progressive ascending weakness starting in the feet and legs. It follows a gastrointestinal or respiratory infection in most cases, with symptoms appearing 1–4 weeks later. The weakness is bilateral and symmetrical, reflexes are absent, and the progression can reach the respiratory muscles — causing life-threatening respiratory failure in approximately 25% of cases. Diagnosis is confirmed by nerve conduction studies and lumbar puncture (elevated CSF protein with normal cell count — albuminocytological dissociation). Treatment with IV immunoglobulin or plasmapheresis reduces disease severity. Most patients recover, though recovery may be incomplete and takes months.

Can weakness be caused by low potassium?

Yes — severe hypokalaemia (low blood potassium, typically below 2.5 mmol/L) can cause generalised muscle weakness, muscle cramps, and in extreme cases respiratory muscle weakness and cardiac arrhythmias. The legs are usually affected first. Common causes of hypokalaemia include diarrhoea and vomiting (gastrointestinal loss), diuretic use (particularly loop and thiazide diuretics), and excessive laxative use. Hypokalaemic periodic paralysis is a rare hereditary condition causing episodic severe weakness. Any sudden generalised weakness in someone on diuretics or with significant fluid losses should include an urgent blood potassium measurement as part of the assessment. Mild-to-moderate hypokalaemia can be corrected with oral potassium supplements; severe hypokalaemia requires IV replacement with cardiac monitoring.

What does it mean if weakness comes and goes?

Weakness that fluctuates — present sometimes and not others, or worsening with activity and improving with rest — is a specific clinical pattern that suggests myasthenia gravis or a periodic paralysis syndrome. Myasthenia gravis produces characteristic fatigable weakness: ptosis appears as the day progresses, double vision comes and goes, and limb weakness is worse after sustained activity. Periodic paralysis (hypokalaemic or hyperkalaemic) produces episodic attacks of weakness, often triggered by specific factors. Fluctuating weakness is distinct from the progressive weakness of a stroke or spinal cord lesion, which does not come and go but rather accumulates. Any pattern of recurring, episodic limb weakness requires neurological assessment to identify the underlying mechanism.

References

1. Saver JL. Time is brain — quantified. Stroke. 2006;37(1):263–266.
2. Rothwell PM, et al. Effect of urgent treatment for TIA and minor stroke. Lancet. 2007;370(9596):1432–1442.
3. Hughes RA, Cornblath DR. Guillain-Barré syndrome. Lancet. 2005;366(9497):1653–1666.
4. Meriggioli MN, Sanders DB. Autoimmune myasthenia gravis. Lancet Neurol. 2009;8(5):475–490.
5. Stone J, et al. Functional neurological disorders. Lancet Neurol. 2020;19(5):355–368.
6. NHS. Stroke. nhs.uk. Updated 2023.
7. Bhatt DL, et al. Clopidogrel plus aspirin versus aspirin after TIA. N Engl J Med. 2006;354(16):1706–1717.
8. Walton J. Disorders of voluntary muscle. Churchill Livingstone; 1994.